These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34836952)

  • 1. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes.
    Ansari-Pour N; Zheng Y; Yoshimatsu TF; Sanni A; Ajani M; Reynier JB; Tapinos A; Pitt JJ; Dentro S; Woodard A; Rajagopal PS; Fitzgerald D; Gruber AJ; Odetunde A; Popoola A; Falusi AG; Babalola CP; Ogundiran T; Ibrahim N; Barretina J; Van Loo P; Chen M; White KP; Ojengbede O; Obafunwa J; Huo D; Wedge DC; Olopade OI
    Nat Commun; 2021 Nov; 12(1):6946. PubMed ID: 34836952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer.
    Han YJ; Liu S; Hardeman A; Rajagopal PS; Mueller J; Khramtsova G; Sanni A; Ajani M; Clayton W; Hurley IW; Yoshimatsu TF; Zheng Y; Parker J; Perou CM; Olopade OI
    Clin Cancer Res; 2024 Jun; 30(11):2609-2618. PubMed ID: 38564595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.
    Pitt JJ; Riester M; Zheng Y; Yoshimatsu TF; Sanni A; Oluwasola O; Veloso A; Labrot E; Wang S; Odetunde A; Ademola A; Okedere B; Mahan S; Leary R; Macomber M; Ajani M; Johnson RS; Fitzgerald D; Grundstad AJ; Tuteja JH; Khramtsova G; Zhang J; Sveen E; Hwang B; Clayton W; Nkwodimmah C; Famooto B; Obasi E; Aderoju V; Oludara M; Omodele F; Akinyele O; Adeoye A; Ogundiran T; Babalola C; MacIsaac K; Popoola A; Morrissey MP; Chen LS; Wang J; Olopade CO; Falusi AG; Winckler W; Haase K; Van Loo P; Obafunwa J; Papoutsakis D; Ojengbede O; Weber B; Ibrahim N; White KP; Huo D; Olopade OI; Barretina J
    Nat Commun; 2018 Oct; 9(1):4181. PubMed ID: 30327465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
    Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
    JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
    Wang S; Pitt JJ; Zheng Y; Yoshimatsu TF; Gao G; Sanni A; Oluwasola O; Ajani M; Fitzgerald D; Odetunde A; Khramtsova G; Hurley I; Popoola A; Falusi A; Ogundiran T; Obafunwa J; Ojengbede O; Ibrahim N; Barretina J; White KP; Huo D; Olopade OI
    Int J Cancer; 2019 Dec; 145(12):3321-3333. PubMed ID: 31173346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
    Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
    Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Ancestry-dependent Differences in Breast Cancer-induced Field Defects in the Tumor-adjacent Normal Breast.
    Nakshatri H; Kumar B; Burney HN; Cox ML; Jacobsen M; Sandusky GE; D'Souza-Schorey C; Storniolo AMV
    Clin Cancer Res; 2019 May; 25(9):2848-2859. PubMed ID: 30718355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 10. Disparities in breast cancer and african ancestry: a global perspective.
    Newman LA
    Breast J; 2015; 21(2):133-9. PubMed ID: 25639288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population.
    Hamilton AM; Van Alsten SC; Gao X; Nsonwu-Farley J; Calhoun BC; Love MI; Troester MA; Hoadley KA
    Cancer Res Commun; 2023 Jan; 3(1):12-20. PubMed ID: 36968228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the genomic heterogeneity of multifocal breast cancer.
    Desmedt C; Fumagalli D; Pietri E; Zoppoli G; Brown D; Nik-Zainal S; Gundem G; Rothé F; Majjaj S; Garuti A; Carminati E; Loi S; Van Brussel T; Boeckx B; Maetens M; Mudie L; Vincent D; Kheddoumi N; Serra L; Massa I; Ballestrero A; Amadori D; Salgado R; de Wind A; Lambrechts D; Piccart M; Larsimont D; Campbell PJ; Sotiriou C
    J Pathol; 2015 Aug; 236(4):457-66. PubMed ID: 25850943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
    Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
    Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample.
    Yoshida R; Hagio T; Kaneyasu T; Gotoh O; Osako T; Tanaka N; Amino S; Yaguchi N; Nakashima E; Kitagawa D; Ueno T; Ohno S; Nakajima T; Nakamura S; Miki Y; Hirota T; Takahashi S; Matsuura M; Noda T; Mori S
    Cancer Sci; 2021 Mar; 112(3):1310-1319. PubMed ID: 33421217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
    Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
    JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in
    Hu L; Su L; Cheng H; Mo C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Zhang J; Xie Y
    Cancer Res; 2021 May; 81(10):2600-2611. PubMed ID: 33727227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network.
    Heng YJ; Hankinson SE; Wang J; Alexandrov LB; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; Eliassen AH; Tamimi RM; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):599-605. PubMed ID: 31932411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological Advancements for Investigating Intra-tumoral Heterogeneity in Breast Cancer at the Bench and Bedside.
    Baek M; Chang JT; Echeverria GV
    J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):289-304. PubMed ID: 33300087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
    Ma D; Jiang YZ; Liu XY; Liu YR; Shao ZM
    Breast Cancer Res Treat; 2017 Feb; 162(1):39-48. PubMed ID: 28093659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.